The aim of this study was to evaluate the use of enamel matrix derivative (EMD) alone or in association with deproteinized bovine bone mineral (DBBM) for the treatment of partially contained intrabony defects. A total of 29 intrabony defects were included. 9 self-contained defects (control group) and 10 partially contained defects (test group 1) were treated with EMD alone, while the other 10 partially contained defects (test group 2) were treated with a combination of EMD and DBBM. In all patients the papilla preservation technique was employed to raise the flap. At 12 months, probing depth (PD), recession (REC) and clinical attachment level (CAL) were respectively 2.3 ± 0.5 mm, 3.3 ± 2.0 mm and 5.6 ± 1.8 mm in the control group, 2.8 ± 0.8 mm, 2.3 ± 2.4 mm, and 5.0 ± 2.8 mm in test group 1, and 3.0 ± 0.7 mm, 3.9 ± 1.5 mm and 6.9 ± 1.1 mm in test group 2. Radiographic parameters confirmed a visible filling of all defects. No significant differences between groups were found. The results showed that partially contained defects could be successfully treated even using EMD alone when an appropriate technique for papilla preservation was applied.
No datasets are available for this submission.
No license information is available for this submission.